Newsweek Europe


KIM JANDA LIKES TO SAY he has engineered immune cells in the lab capable of protecting the human body against virtually “everything that’s walked or crawled”— including some of the most toxic known diseases, including anthrax, botulinum neurotoxin, and ricin. When someone close to Janda developed a drug addiction, it was only natural that the Scripps Research Institute scientist would try to help. Might it be possible, he wondered, to create a pill or a shot that could protect addicts from the consequences of their slips, by neutralizing the drug before it could get them high or cause an overdose? That way, it might be possible to keep addicts from relapsing, which sometimes proves fatal.

The need for such an intervention is more urgent than ever. In the more than two decades since Janda began plugging away on his addiction vaccines, the opioid epidemic took the fast track. Addiction has claimed 750,000 lives since 1999, according to the Centers for Disease Control. Scientists and health care officials in the U.S. have struggled to keep up and develop new responses. The drug cartels have fought to keep their firm grip on addicts with new products that are cheaper and more potent. Their latest is fentanyl, a synthetic drug that is cheap to make and all too easy to overdose on—and may be responsible for a recent rise in the overdose death rate. This year, COVID-19-related developments are adding to the downward spiral.

Over the last three to four months overdose deaths have increased nationwide by close to 15 percent, says Shawn Ryan, Chair of Legislative Advocacy for the American Society of Addiction Medicine. Ryan is also president and chief medical officer of BrightView Health, a 20-site treatment network in Ohio and Kentucky, long

Vous lisez un aperçu, inscrivez-vous pour en lire plus.

Plus de Newsweek Europe

Newsweek Europe7 min de lecture
Why I Accepted a Medal from Donald Trump
THE DAY BEFORE PHOTOGRAPHER Nick Ut was scheduled to receive the Medal of Arts from Donald Trump, another famous soon-to-be medal recipient publicly declined the honor: Bill Belichick, head coach of the New England Patriots and longtime friend of the
Newsweek Europe2 min de lecture
Lorraine Toussaint
ONE THING IS CERTAIN ABOUT GREAT ACTORS, THEY CAN’T BE PIGEONHOLED. “I may indeed be perceived as a character actor, but I just think of myself as an actress that serves the work,” says Lorraine Toussaint, who co-stars with Queen Latifah in the new d
Newsweek Europe7 min de lectureAmerican Government
Can Biden Succeed Where Obama Failed?
TWELVE YEARS AFTER JOE BIDEN was sworn in as the vice president of hope and change, hope is in short supply and the need for change is even more acute. Progressives have a rare opportunity to enact their agenda—but they will need to play the kind of